(Q52135420)

22 April 2018

title

Cognitive effects of L-deprenyl in Alzheimer's disease. (English)

1 reference

22 April 2018

author name string

P N Tariot

1

1 reference

22 April 2018

T Sunderland

2

1 reference

22 April 2018

H Weingartner

3

1 reference

22 April 2018

D L Murphy

4

1 reference

22 April 2018

J A Welkowitz

5

1 reference

22 April 2018

K Thompson

6

1 reference

22 April 2018

R M Cohen

7

1 reference

22 April 2018

publication date

1 January 1987

1 reference

22 April 2018

published in

Psychopharmacology

1 reference

22 April 2018

volume

91

1 reference

22 April 2018

issue

4

1 reference

22 April 2018

page(s)

489-495

1 reference

22 April 2018

https://scigraph.springernature.com/pub.10.1007/bf00216016

exact match

0 references

cites work

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00216016

Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study

21 January 2018

1 reference

12 December 2020

High-dose naloxone affects task performance in normal subjects

1 reference

12 December 2020

Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment

1 reference

12 December 2020

Development of a Rating Scale for Primary Depressive Illness

1 reference

12 December 2020

The Global Deterioration Scale for assessment of primary degenerative dementia

1 reference

12 December 2020

(-)Deprenyl in the treatment of Parkinson's disease.

1 reference

12 December 2020

Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease

1 reference

12 December 2020

Catecholamines and memory: enhanced verbal learning during L-DOPA administration

1 reference

12 December 2020

The effect of methylphenidate on test performance in the cognitively impaired aged

1 reference

12 December 2020

Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and down's syndrome

1 reference

12 December 2020

Memory Functions in Depression

1 reference

12 December 2020

Catecholamine theories of reward: A critical review

1 reference

12 December 2020

Effort and cognition in depression.

1 reference

12 December 2020

L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition

1 reference

12 December 2020

Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome

1 reference

12 December 2020

Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.

1 reference

12 December 2020

Hormonal influences on memory

1 reference

12 December 2020

Intrusions as a sign of Alzheimer dementia: chemical and pathological verification.

1 reference

12 December 2020

Ageing, monoamines, and monoamine-oxidase levels.

1 reference

12 December 2020

Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia

1 reference

12 December 2020

Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type

1 reference

12 December 2020

Changes of Biogenic Amines and Their Metabolites in Postmortem Brains from Patients with Alzheimer-Type Dementia

1 reference

12 December 2020

l-Deprenyl in atypical depressives.

1 reference

12 December 2020

Measurement of cholinergic drug effects on memory in Alzheimer's disease

1 reference

12 December 2020

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

1 reference

12 December 2020

Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of doses.

1 reference

12 December 2020

Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer.

1 reference

12 December 2020

A psychobiologic analysis of cognitive failures. Structure and mechanisms.

1 reference

12 December 2020

Neurochemical characteristics of early and late onset types of Alzheimer's disease

1 reference

12 December 2020

Deprenyl administration in man: A selective monoamine oxidase B inhibitor without the ?cheese effect?

1 reference

12 December 2020

Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect?

1 reference

12 December 2020

Forms of memory failure.

1 reference

12 December 2020

Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia.

1 reference

12 December 2020

d-Amphetamine: effects on memory in a depressed population

1 reference

12 December 2020

A continuous performance test of brain damage.

1 reference

12 December 2020

d-Amphetamine in Elderly Patients Refractory to Rehabilitation Procedures

1 reference

12 December 2020

Frequency-Dependent Noradrenergic Modulation of Long-Term Potentiation in the Hippocampus

1 reference

12 December 2020

Deprenyl is metabolized to methamphetamine and amphetamine in man

1 reference

12 December 2020

Changes in the brain catecholamines in patients with dementia of Alzheimer type.

1 reference

12 December 2020

Cognitive processes in depression

1 reference

12 December 2020

Cognitive dysfunction and imipramine in outpatient depressive.

1 reference

12 December 2020

The pharmacology of memory: a neurobiological perspective

1 reference

12 December 2020

Effortful and automatic cognitive processes in depression.

1 reference

12 December 2020

L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation

1 reference

12 December 2020

Influence of Affective States and Psychoactive Drugs on Verbal Learning and Memory

1 reference

12 December 2020

Psychostimulant treatment of depressive disorders secondary to medical illness

1 reference

12 December 2020

The relative efficacy of l-deprenyl, a selective monoamine oxidase type B inhibitor, in endogenous and nonendogenous depression

1 reference

12 December 2020

Impaired Learning and Decreased Cortical Norepinephrine after Bilateral Locus Coeruleus Lesions

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00216016

1 reference

22 April 2018

PubMed ID

3108930

1 reference

22 April 2018